Myrbetriq 8 mg/mL (Mirabegron GRANULE, FOR SUSPENSION, EXTENDED RELEASE) 8 mg/mL

Myrbetriq 8 mg/mL is an extended-release oral suspension containing mirabegron, used for managing overactive bladder symptoms. This medication helps control bladder function and reduce urinary urgency.

Strength

8 mg/mL

Pack Size

1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE

Manufacturer / TM Owner

Astellas Pharma US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Myrbetriq 8 mg/mL is primarily used to treat symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence. It works by relaxing the bladder muscle, helping to improve bladder control and reduce the urge to urinate frequently. This medication is often prescribed for individuals experiencing discomfort or inconvenience due to overactive bladder.

Side Effects

Common effects of Myrbetriq 8 mg/mL may include dry mouth, constipation, and headaches. Some users might experience dizziness or fatigue. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Myrbetriq 8 mg/mL should be used with caution in individuals with certain medical conditions, such as liver or kidney problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Myrbetriq 8 mg/mL may interact with other medications, including those metabolized by the liver's CYP2D6 enzyme. It is advisable to avoid alcohol while using this medication, as it may increase the risk of side effects. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Myrbetriq 8 mg/mL is used to manage symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence.

Myrbetriq 8 mg/mL is an oral suspension that should be taken as directed by a healthcare professional, typically once daily.

Common side effects may include dry mouth, constipation, headaches, dizziness, and fatigue.

Myrbetriq 8 mg/mL may interact with other medications, so it is important to consult a healthcare professional before combining it with other treatments.

The safety of Myrbetriq 8 mg/mL for long-term use should be discussed with a healthcare professional, who can provide personalized advice based on individual health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.